News Releases - Achieve Life Sciences

News Releases

Home

Home ivps4 2017-06-16T21:39:52+00:00

News Releases

Month Year

Month Year

Investor Alerts

Aug 3, 2021

Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
Jul 22, 2021

Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
Jun 29, 2021

Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline

ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States
Jun 3, 2021

Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
Jun 2, 2021

Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference

Show per page

Stock Info